Financials in USD. Standardized financial statements.
A compact view of how Lumos Diagnostics Holdings Limited turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue? | $12.50M | $11.13M | $10.54M | $11.63M | $18.98M | $5.78M | $4.48M | $1.92M |
| Revenue Growth? | +12.3% | +5.7% | -9.4% | -38.7% | +228.2% | +29.1% | +133.7% | 0.0% |
| Cost of Revenue? | $4.59M | $4.03M | $14.71M | $7.17M | $18.34M | $3.27M | $2.44M | $1.08M |
| Gross Profit? | $7.91M | $7.10M | -$4.28M | $4.46M | $638,084 | $2.51M | $2.04M | $837,767 |
| Gross Margin? | +63.2% | +63.8% | -40.6% | +38.3% | +3.4% | +43.4% | +45.5% | +43.7% |
| Operating Expenses? | $15.75M | $14.22M | $5.79M | $15.18M | $11.71M | $13.20M | $4.98M | $2.19M |
| Operating Income? | -$7.84M | -$7.12M | -$6.56M | -$23.89M | -$11.07M | -$10.69M | -$2.94M | -$1.35M |
| EBITDA? | -$4.63M | -$5.44M | -$2.84M | -$40.24M | -$10.47M | -$8.24M | -$2.41M | -$1.20M |
| Income Before Tax | -$7.18M | -$8.59M | -$8.97M | -$45.72M | -$15.13M | -$9.32M | -$5.20M | -$1.26M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | -$59,320 | -$610,969 | -$3 |
| Net Income? | -$7.18M | -$8.59M | -$8.88M | -$45.72M | -$15.13M | -$9.26M | -$4.59M | -$1.26M |
| EPS? | $-0.01 | $-0.02 | $-0.04 | $-0.30 | $-0.09 | $-0.05 | $-0.03 | $-0.01 |
| Diluted EPS? | $-0.01 | $-0.02 | $-0.04 | $-0.30 | $-0.09 | $-0.05 | $-0.03 | $-0.01 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality